The dispute over valuable patents to the gene-editing tool CRISPR is back on, and the belligerents are once again the Broad Institute of Cambridge, Massachusetts, and the University of ...
The U.S. patent office has declared an interference between a dozen key patents awarded to the Broad Institute on the genome-editing technology CRISPR and 10 CRISPR patent applications submitted by the ...
The Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office (USPTO) has declared an interference between 10 University of California patent applications and multiple previously ...
The first day of summer has arrived, and so has STAT’s annual book list of great reads in health, science, and medicine.
Read on for recommendations from CRISPR pioneer Jennifer ...
Jeff Carroll had been married for six months when he and his wife decided not to have children. Carroll, 25 years old and a former corporal in the US ...
As far as experts are concerned, the technology of gene editing is nowhere near ready to be used to create gene-edited babies. This, of course, is separate from the ...
The drug maker GlaxoSmithKline announced Thursday that it would team up with some of the nation’s most prominent CRISPR researchers to use the gene-editing technology in a search for ...
Pioneers in the field of gene-editing technology will collaborate with one of the world's biggest drugmakers on accelerating the search for new medicines using the promising tool known as ...
GlaxoSmithKline is launching a rare partnership with an American university through which the UK drugmaker will fund more than 20 scientists at a new laboratory focused on human genome ...
When Hal Barron unveiled his grand plan to turn GlaxoSmithKline’s R&D group around, he championed genetics as one of two key focuses for the UK pharma giant, announcing a ...
GlaxoSmithKline is joining forces with the University of California to dig into how gene mutations cause disease and to use CRISPR to discover new drugs. The partners will set up a ...
Drug company GlaxoSmithKline announced today that it will establish a laboratory for CRISPR technologies as part of a five-year collaboration with University of California researchers.
The new Laboratory for Genomics ...
GlaxoSmithKline’s latest move to reinvigorate R&D is a collaboration with two of the biggest names in CRISPR research to develop new gene editing technologies and use them to identify ...
The University of California announced a major deal Thursday with the drug company GlaxoSmithKline, in which the pharmaceutical firm will provide up to $67 million over five years to ...
Top CRISPR researchers at two University of California (UC) campuses have teamed up with pharmaceutical giant GlaxoSmithKline (GSK) to form a new laboratory in San Francisco that will exploit the ...
The pharmaceutical company GlaxoSmithKline (GSK) today announced a five-year collaboration with UC Berkeley and UCSF to establish a laboratory where state-of-the-art CRISPR techniques will be used to explore how ...
New ‘Laboratory for Genomics Research’ unites CRISPR pioneers with industry expertise to help unravel mysteries of the human genome
Issued: London and San Francisco - GlaxoSmithKline plc today announced a ...
The proposal follows a Chinese scientist who claimed to have created twins from edited embryos last year.
A Russian scientist says he is planning to produce gene-edited babies, an act ...
Gene editing promises to revolutionize medicine. But how safe is safe enough for the patients testing these therapies?
By all accounts Jesse Gelsinger was a sweet, sharp-witted, if not particularly ambitious kid ...
USPTO issues sixth CRISPR-Cas9-related patent to University of California for genome editing and modulation of gene expression
BERKELEY, Calif., June 4, 2019 /PRNewswire/ -- The U.S. Patent and Trademark Office has issued a ...
The 2018 birth of two gene-edited babies shocked the world. However, a study suggesting they have a risk of early death has now been retracted.
Editor’s Note: On October 8, ...
The co-founder of the World Science Festival, Brian Greene, opened the 2019 festival on Tuesday evening by noting the capacity of our species to take hold of a process that ...
It’s happened. The first children genetically engineered with the powerful DNA-editing tool called CRISPR-Cas9 have been born to a woman in China. Their altered genes will be passed to ...
Six months after a Chinese scientist was widely scorned for helping to make the world’s first gene-edited babies, he remains out of public view, and new information suggests that ...
The U.S. Patent and Trademark Office today issued a patent to the University of California (UC), the University of Vienna and French biologist Emmanuelle Charpentier that covers methods of ...
Award-winning scientist Jennifer A. Doudna, PhD is renowned for her fundamental work and leadership in developing CRISPR-mediated genome editing alongside her colleague Emmanuelle Charpentier. The power and versatility of ...
When Rachel Haurwitz started her biology Ph.D. at the University of California, Berkeley, the award-winning biochemist Jennifer Doudna suggested Haurwitz investigate part of a bacterial immune system. She studied how ...
Written by Dr. Jennifer Doudna, Professor of Chemistry and Molecular and Cell Biology, UC Berkeley
The UN’s Sustainable Development Goals (SDGs) are an important call to action.
The data, consensus of ...
Two sisters entered the world prematurely one October night last year by emergency caesarean section. Staff at the Chinese hospital swaddled them in white, laying them in incubators.
The twins ...
Powerful gene-editing tools have the potential to heal—or to harm. Now there’s a race to develop the antidote to the next bioweapon.
In September 2016, Jennifer Doudna called a new ...
Distillations talks to biochemist Jennifer Doudna about the discovery of CRISPR-Cas9, the tool’s promise, and dangers of its misuse.
Biochemist Jennifer Doudna and her colleagues rocked the research world in ...
A fourth U.S. patent covering CRISPR-Cas9 claims was granted today to the Regents of the University of California (UC), the University of Vienna, and CRISPR pioneer Emmanuelle Charpentier, PhD, ...
While ethicists debate the applications of blockbuster gene-editing tool Crispr in human healthcare, an inventor of the tool believes it has a more immediate application: improving our food.
"I think ...
Scientist He Jiankui showed the world how human embryo editing is relatively easy to do but incredibly difficult to do well. Going against the consensus in the scientific community ...
Jennifer Doudna learned by email that a scientist in China had used the blockbuster gene-editing tool she'd helped invent to reportedly edit the DNA of a pair of twin baby ...
Conversations host Harry Kreisler welcomes Professor Jennifer Doudna of UC Berkeley for a discussion of her intellectual odyssey that led to the discovery of CRISPR-Cas9, a revolutionary tool for ...
Prof Jennifer Doudna, one of the pioneers of Crispr-Cas9 gene editing, explains how this revolutionary discovery enables precise changes to our DNA, which can be used to correct mutations ...
It’s arguably the most cutting-edge and potentially lucrative area of biomedical science and now, to protect their investments, companies commercializing CRISPR genome editing technology are looking to shore up ...
Our technological capacity to make changes to genomic data has expanded exponentially since the 2012 discovery of CRISPR-Cas9 as an RNA-programmable genome editing tool.
Over the past seven years, this ...
Scientists and ethicists from seven nations on Wednesday called for a moratorium on gene-editing experiments designed to alter heritable traits in human babies. It's the latest alarm sounded by ...
